Squamous cell carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Association between the V109G polymorphism of the p27 gene and the risk and progression of oral squamous cell carcinoma.
|
15217930 |
2004 |
Squamous cell carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The aim of the present study was to examine the expression of Jun activation domain-binding protein 1(Jab1) and p27 and to elucidate its clinicopathologic significance in a larger series of squamous cell carcinoma (SCC) of the esophagus.
|
19349901 |
2009 |
Squamous cell carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Finally, we found that PCNA, p27 may interact with CDK1 which promote IP cell proliferation and correlate to sinonasal squamous cell carcinoma.
|
25013792 |
2014 |
Squamous cell carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Immunohistochemical staining of p27 was performed in samples of normal cervical tissue (30 samples), cervical intraepithelial neoplasias (CINs; 17 samples), and invasive squamous cell carcinoma (SCC; 25 samples).
|
11753978 |
2001 |
Squamous cell carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
1,25(OH)2 vitamin D3 induces elevated expression of the cell cycle-regulating genes P21 and P27 in squamous carcinoma cell lines of the head and neck.
|
11270487 |
2001 |
Squamous cell carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Polygodial, P3, and P27 all significantly decreased OSCC tumor growth, with P27 being equipotent with polygodial and P3 being the least efficacious.
|
30320372 |
2018 |
Squamous cell carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Several novel findings were obtained: (i) cytoplasmic p27 was observed in 8.6%, most frequently in SCC (13.3%), and correlated with nodal metastasis (P=.0044), (ii) significant inverse correlation between nuclear p27 and Pirh2 expression was observed by statistical analysis and at the cellular level, and (iii) cytoplasmic Pirh2 and total (cytoplasmic and/or nuclear) Pirh2 were significantly correlated with the nodal status (P=.0225, 0.0314), the pathological stage (P=.0213, 0.0475) and recurrence-free survival (P=.0194, 0.0482, respectively) in AC.
|
28601655 |
2017 |
Squamous cell carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
In this study, we examined Skp2 and p27 protein expression by immunohistochemistry in normal oral epithelium and in different stages of malignant oral cancer progression, including dysplasia and oral squamous cell carcinoma.
|
11309491 |
2001 |
Squamous cell carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
In this study, we noticed that the levels of p21 and p27 increased in two oral squamous cell carcinoma cell lines with high confluence.
|
22469187 |
2012 |
Squamous cell carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
In the present study, we investigated if small interfering RNA (siRNA)-mediated gene silencing of Skp2 can be employed in order to inhibit p27 down-regulation in oral squamous cell carcinoma.
|
15767556 |
2005 |
Squamous cell carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Adenocarcinomas (AdCs) exhibited higher p27 levels compared to squamous cell carcinomas (SqCCs) (p < 0.01).
|
11474135 |
2001 |
Squamous cell carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Decreased PTEN and p27 expression were associated with advanced tumor stage in squamous cell carcinomas.
|
19691991 |
2010 |
Squamous cell carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
In SCCs there was no association between p27 expression and the presence of keratinization and tumor grade. p21 and p53 expressions were not associated with IPs (dysplastic and nondysplastic) and SCCs.
|
12869921 |
2003 |